Position in ATRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$528
+$254 QoQ
Shares Held
46
-20.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 36 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ATRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. ATRA ranks #361 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
4,377,120 | $306,529,713 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
399,847 | $249,320,598 | |
| 3 | ARGX |
Argenx SE
|
157,958 | $146,548,693 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
262,258 | $130,271,416 | |
| 5 | BNTX |
BioNTech SE
|
1,319,517 | $122,781,056 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
552,710 | $103,511,528 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
1,079,015 | $102,689,857 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,155,442 | $86,057,320 |
All Filings in ATRA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $528 | 46 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $274 | 58 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $832 | 46 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $716 | 50 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $386 | 50 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $297 | 50 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $811 | 61 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $455 | 56 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $312,154 | 36,724 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $265,858 | 383,082 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $151,971 | 296,240 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $29,175 | 19,713 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $121,780 | 75,640 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $747,927 | 257,906 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $351,481 | 107,159 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $749,449 | 198,267 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $209,434 | 26,885 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $123,910 | 13,338 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $775,344 | 49,197 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $520,800 | 29,095 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $329,317 | 21,178 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $517,534 | 36,040 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $2,085,510 | 106,241 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $222,017 | 17,131 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $115,467 | 7,925 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $234,476 | 27,553 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||